Meredith (MDP) –
-
Travel + Leisure Announces the 2024 It List of Best New Hotels
-
PEOPLE DEBUTS 50TH ANNIVERSARY ISSUE FEATURING 11 COVER STARS
-
FOOD & WINE ANNOUNCES WINNERS OF ITS 2024 GLOBAL TASTEMAKERS AWARDS
-
SOUTHERN LIVING ANNOUNCES 2024 SOUTH'S BEST AWARDS
-
BEAUTIFUL KITCHENS & BATHS MAGAZINE UNVEILS 30 MOST INNOVATIVE PRODUCTS FOR 2024
-
2024 REAL SIMPLE HOME to Return to Brooklyn This Fall
-
THE PREMIER CULINARY EXPERIENCE IS COMING TO THE EAST COAST
-
COSTA RICA NAMED TRAVEL + LEISURE'S 2024 DESTINATION OF THE YEAR
-
Registration Opens for the REAL SIMPLE Women's Half Marathon, Set to Take Place on Sunday, April 28
-
REAL SIMPLE Unveils Sixth Annual REAL SIMPLE HOME at Quay Tower in Brooklyn, New York
-
Medexus Pharmaceuticals Announces C$10 Million Bought-Deal Public Offering of Units
-
SOUTHERN LIVING UNVEILS 2023 IDEA HOUSE IN SEPTEMBER ISSUE COVER STORY
-
REAL SIMPLE Announces Winners of the 2023 Smart Money Awards
-
Travel + Leisure Announces Winners of 2023 World's Best Awards Revealing the Top Cities, Islands, Hotels, Cruise Lines and More
-
FOOD & WINE Honors The 15 Game Changers Impacting The Way We Eat And Drink In 2023
-
2023 REAL SIMPLE HOME to Debut in NYC's Brooklyn Heights This Fall
-
FOOD & WINE Classic in Aspen 40th Anniversary Special Digital Issue Debuts Today
-
FOOD & WINE Announces Its Inaugural 2023 Global Tastemakers Awards
-
REAL SIMPLE's "Get. It. Done." Home Launches Today with Virtual Experience and Editorial Feature to Inspire Your Next Home Project
-
Medexus to Participate in the 2023 Bloom Burton & Co. Healthcare Investor Conference
-
Medexus Expects Record Revenue for Fiscal Year 2023 and Provides Business Update
-
Medexus Announces New License Deal for Topical Terbinafine
-
Medexus Announces US$58.5 million in New Credit Facilities
-
Southern Living Announces Winners of 2023 South's Best Awards
-
Medexus to Participate in 35th Annual Roth Conference
-
Medexus Announces Another Record Quarter with Fiscal Q3 2023 Revenue of US$28.7 Million, a 35% Increase Over Fiscal Q3 2022
-
Medexus Welcomes Two New Board Members
-
Medexus Secures Public Reimbursement for Cuvposa® in Quebec
-
Medexus Schedules Third Fiscal Quarter 2023 Conference Call
-
Medexus Expects Record Revenue for Fiscal Q3 2023 and Provides Business Update
-
THE FOOD & WINE CLASSIC IN ASPEN 2023 TO CELEBRATE 40 YEARS OF ICONS & INNOVATORS
-
Medexus Announces Strongest Quarter in Company History with Fiscal Q2 2023 Revenue of US$27.7 Million, a 55% Increase Over Fiscal Q2 2022
-
Medexus Schedules Second Quarter 2023 Conference Call
-
Medexus Announces Preliminary Revenue Results for Second Fiscal Quarter 2023
-
Medexus and MidCap Agree to Increase in MidCap’s Revolving Loan Commitment Amount
-
Medexus Provides Update on Treosulfan NDA Resubmission and Provides Business Update
-
Medexus Holds Annual Meeting of Shareholders and Announces Election of Board of Directors
-
Medexus Announces Record Fiscal Q1 2023 Revenue of US$23.0 Million, a 33% Increase versus Fiscal Q1 2022
-
Medexus Schedules First Quarter 2023 Conference Call
-
Treosulfan NDA Resubmitted to FDA
-
Medexus Generates Revenue of US$76.7 Million in Fiscal Year 2022 and US$20.3 million in Fiscal Q4 (Strongest Q4 Revenue in Company History)
-
Medexus Schedules Fourth Quarter and Fiscal Year 2022 Conference Call
-
Treosulfan Pivotal Study Results Published
-
Medexus Pharmaceuticals Provides Update on Resubmission of Treosulfan NDA
-
Medexus Pharmaceuticals Announces Resubmission of Treosulfan NDA
-
Medexus to Present at the Bloom Burton & Co. Healthcare Investor Conference
-
Medexus to Participate in the 34th Annual Roth Conference
-
Medexus Pharmaceuticals Announces Deal for Gleolan in the United States
-
Medexus Pharmaceuticals Announces Normal Course Issuer Bid, or NCIB, for Convertible Debentures
-
Medexus Pharmaceuticals Generated $21.3M in Fiscal 2022 Third Quarter Revenues and Achieved $1.9M Positive EBITDA for the Three Months Ended December 31, 2021
Back to MDP Stock Lookup
